Talvez você já tenha ouvido falar sobre a relação entre a infecção por papilomavírus humano (HPV) e certos tipos de cânceres cervicais, mas você sabia que a infecção por HPV também está relacionada a um maior risco de câncer bucal e de garganta?
Es posible que haya escuchado acerca de la conexión entre la infección por el virus del papiloma humano (VPH) y ciertos tipos de cáncer del cuello del útero, pero ¿sabía que la infección por el VPH también está relacionada con un mayor riesgo de presentar cáncer de boca y de garganta?
A new study conducted by scientists at the American Cancer Society and Brookdale University Hospital Medical Center reveals recent mortality rates for all major cancers decreased in most of the studied countries except lung cancer in females and liver cancer in males, where increasing rates were observed in most countries. The research also showed that cancer-specific mortality rates varied substantially across countries, with rates of lung and cervical cancer varying by 10-fold. The study was published today in the journal Cancer Epidemiology, Biomarkers & Prevention, a publication of the American Association for Cancer Research.
Skin cancer is the most prevalent form of cancer in the United States, with over 5 million cases diagnosed annually. The Centers for Disease Control and Prevention reports that melanoma alone accounts for more than 8,000 deaths each year. Thankfully, skin cancer is highly preventable, making it crucial to prioritize protection. Below are some of the latest headlines in the Dermatology channel.
Osteoporosis — a condition that causes bones to become weak and more susceptible to fracture — affects more than 10 million Americans. It occurs when a person’s body does not properly replenish the components of their bone tissue.
Dipen Parekh, M.D., founding director of the Desai Sethi Urology Institute at the University of Miami Miller School of Medicine, has been awarded the Sushruta Award by the Indian American Urological Association (IAUA) for his contributions to the field of urology.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
A new paper in the European Journal of Endocrinology, published by Oxford University Press, indicates that overweight boys tend to have lower testicular volume, putting them at risk for infertility in adulthood.
A banner year for Desai Sethi Urology Institute at urology’s premier meeting, the American Urological Association (AUA) 2023, held April 28-May 1 in Chicago where faculty and researchers led and debated during plenary sessions and presented novel research in topics spanning prostate and bladder cancers to sexual function and robotic surgery.
A decline in New York’s childbirth rate is showing no sign of reversing and many women are waiting longer to have children, according to newly compiled data from the Program in Applied Demographics (PAD) in the Cornell Jeb E. Brooks School of Public Policy.
Thyrotoxic periodic paralysis (TPP), a rare neurological condition causing limbs to go limp, may be an underrecognized cause of paralysis in young Hispanic men, a review of data by UT Southwestern Medical Center endocrinologists shows.
For millions of Americans that suffer from seasonal allergies (pollen and mold), climate change is exacerbating an earlier, longer, and overall worse allergy season.
Novel research in sexual health by investigators at the Desai Sethi Urology Institute (DSUI) at the University of Miami Miller School of Medicine was presented at the 2023 American Urological Association (AUA), one of the world's most important urology meetings, and simultaneously published in, the Journal of Urology, one of the highest impact journals in the specialty.
Young adults who beat cancer face unique challenges later on in their adult lives. Researchers create an intervention that will improve psychosocial function in an underserved cancer survivor group, young adults who survived testicular cancer.
Loyola Medicine Director of Male Reproductive Medicine Denise Asafu-Adjei is available for interviews to discuss male infertility and infertility awareness week.
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center and the Department of Urology at the David Geffen School of Medicine at UCLA will be joining thousands of urology experts on April 28 to May 1 for the American Urological Association (AUA) Annual Meeting.
Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.
The time period in which muscles heal after injury may depend on biological sex, and applying personalized treatment may help optimize recovery, according to a new study.
Vitamin D deficiency could be the reason African American men experience more aggressive prostate cancer at a younger age compared with European American men, new research from Cedars-Sinai Cancer suggests.
Discovery of a gene in multiple mammalian species could pave the way for a highly effective, reversible and non-hormonal male contraceptive for humans and animals.
Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances across the full spectrum of cancer research at the American Association for Cancer Research (AACR) Annual Meeting 2023 from April 14-19 in Orlando, Florida.
In this special episode, MSK's Dr. Diane Reidy-Lagunes sits down with renowned journalist and cancer screening advocate Katie Couric at The Paley Center for Media in New York City. After losing her first husband to colon cancer in 1997, Katie made history when she received her first colonoscopy on-air as host of the Today show, inspiring millions of Americans to do the same in a phenomenon known as the Couric Effect. Her role as the “screen queen” has continued ever since, taking on new meaning last year when she revealed her own breast cancer diagnosis.
In the Nature Cancer study, researchers led by Dana-Farber's Himisha Beltran, MD, and Martin Bakht, PhD, found that PSMA expression is lower in liver metastases than in other parts of the body, regardless of expression of the androgen receptor. They also found that some tumors that test negative for the AR do express PSMA and that some AR-positive tumors don't – which led them to look for a control mechanism that doesn't involve the AR. Their search revealed that the HOXB13 protein as a key regulator of PSMA.
A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.
A new study from UCLA researchers finds sex-specific brain signals that appear to confirm that different drivers lead men and women to develop obesity.
Patients with obstructive sleep apnea (OSA) often show cognitive deficits, but these have traditionally been attributed to co-morbidities such as as systemic hypertension, cardiovascular and metabolic diseases, and type 2 diabetes.
Exposure to female odours and pheromones causes weight loss and extend the life spans of mice, which may have implications for humans, University of Otago researchers have found.
The number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable-intermediate-risk cancers, according to a study published today in JAMA Internal Medicine.
Loyola Medicine will open a new urology clinic at Gottlieb Memorial Hospital on Monday, April 3. The clinic will be located in the Gottlieb Professional Office Building, Suite 414.
A rapid genetic testing model for patients with advanced prostate cancer can more quickly identify those with "actionable" gene variants eligible for newer targeted therapies, reports a clinical trial in the May issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Researchers at Sylvester Comprehensive Cancer Center and the Desai Sethi Urology Institute are pioneering research to harness machine learning for the diagnosis and prognosis of prostate cancer, using magnetic resonance imaging (MRI).
Human papillomaviruses (HPVs) cause several cancers in both men and women, including 91% of cervical cancers, 91% of anal cancers and 75% of vaginal cancers, according to the Centers for Disease Control and Prevention. Most of these cancers are caused by just a handful of HPV virus types.